The inhibitory effects of resveratrol on inflammatory cytokine, TGF-β, and hypoxia-induced VEGF secretion by human RPE cells have been investigated by Nagineni et al. The goal was to demonstrate resveratrol’s usefulness as a nutraceutical supplement that may control CNV processes in AMD [96]. This evidence concerns the gene VEGFA and age-related macular degeneration.